GAN & LEE PHARMACEUTICALS.

Estimates Revisions Gan & Lee Pharmaceuticals.

Equities

603087

CNE100003ZH1

End-of-day quote Shanghai S.E. Other stock markets 12/09/2024			5-day change	1st Jan Change
38.57 ^CNY	-1.08%		-3.82%	-26.74%

09-06	Gan & Lee Pharmaceuticals. announces an Equity Buyback for CNY 300 million worth of its shares.	CI
09-05	Gan & Lee Pharmaceuticals. authorizes a Buyback Plan.	CI

Turnover - Evolution of Analysts' Estimates

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

EBIT - Evolution of Analysts' Estimates

Dividend / Share (DPS) - Evolution of Analysts' Estimates

Cash or Net Debt - Evolution of Analysts' Estimates

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. EPS revision	1m. Revenue rev.	1y. EPS revision	1y. Revenue rev.
	GAN & LEE PHARMACEUTICALS.
	CSL LIMITED
	SAMSUNG BIOLOGICS CO.,LTD.
	UCB
	BIOGEN INC.
	BIOMARIN PHARMACEUTICAL INC.
	BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
	INCYTE CORPORATION
	ALTEOGEN INC.
	SWEDISH ORPHAN BIOVITRUM AB
	Average
	Weighted average by Cap.

See all sector revisions

Turnover

Estimates Revisions:

Earnings Per Share (EPS)

Estimates Revisions:

EBIT

Estimates Revisions:

Dividend / Share (DPS)

Estimates Revisions:

Cash or Net Debt

Estimates Revisions:

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW